Researchers have found that central body fat, especially around the abdomen, is more strongly linked to psoriasis risk than total body fat, particularly in women. This link between central fat and ...

May 27, 2025 — Researchers have found that central body fat, especially around the abdomen, is more strongly linked to psoriasis risk than total body fat, particularly in women. This link ...

Even when medication clears skin symptoms, people with psoriasis can still have inflammation throughout their bodies that increases the risk of obesity, heart disease, and liver issues.

Researchers conducted a systematic review of 14 studies that included 169 patients (mean age, 46.8 years; 74% women) with psoriasis who underwent MBS. Participants underwent various surgical ...

Psoriasis attacks healthy cells, causing inflammation that leads to plaques and other skin changes. Some of the same underlying triggers that drive psoriasis may also pose problems for your heart ...

Ustekinumab offers superior itch relief compared to guselkumab in severe psoriasis, despite guselkumab's better skin lesion improvement. The study involved 108 patients, with 90.4% of ustekinumab ...

Inflammation tends to remain in people with psoriasis, despite their skin responding well to treatment with biologics, latest evidence has revealed. Residual inflammation is associated with an ...

Alumis Inc. has announced the successful completion of patient enrollment in its pivotal Phase 3 ONWARD clinical program for ESK-001, a treatment for moderate-to-severe plaque psoriasis ...

FDA Approves Topical Foam for Plaque Psoriasis of the Scalp and Body By Lori Solomon HealthDay ReporterTUESDAY, May 27, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved ...

BMS has previously said it reckons Sotyktu could become a $4 billion seller at its peak, fuelled by head-to-head studies showing it was more effective at treating moderate-to-severe psoriasis than ...

Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra ...

However, they are sometimes signs of a condition requiring treatment, such as psoriasis, contact dermatitis, or head lice. Treatment options for scalp sores or scabs depend on the cause but ...